Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod

por Correale, Jorge, Chiquete, Erwin, Milojevic, Snezana, Frider, Nadina, Bajusz, Imre
Publicado 2014

Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod

por Correale, Jorge, Chiquete, Erwin, Boyko, Alexey, Beran, Roy G, Strauch, Jorge Barahona, Milojevic, Snezana, Frider, Nadina
Publicado 2016